Reboxetine for the treatment of patients with cocaine dependence disorder

Human Psychopharmacology

Volumn 20, Issue 3, 2005, Pages 189-192

  Szerman, N ^a   Peris, L ^b   Mesias B ^c   Colis, P ^c   Rosa, J ^c   Prieto, A ^c,e   Caceres A M ^d   Vega, P ^d   Garcia R ^d   Soto, C ^d   Sujar, M ^d   Garcia de Merlo G ^d   Bartolome C ^d   Garcia T ^d   Puerta, C ^d   Lagares, A ^d   Garcia I ^d   Garrido, C ^d   Aragon C ^d   Brasal, M F ^d   Heras, S ^d   Gutierrez, P ^d   De la Fuente, R ^d   Lopez C ^d   Aparicio, L ^d   Hernandez C ^d   Picazo, I ^d   de Blas, J ^d   Ortega, M ^d   Gonzalez I ^d   more..

^a Moratalaz Mental Health Department   (Spain)

^b Benito Menni   (Spain)

^c Madrid City Council   (Spain)

^d Reboxetine Use Cocaine Dependence ^*

^e PMCD Department

Author keywords

Cocaine dependence treatment; Noradrenergic Function; Reboxetine

Indexed keywords

COCAINE; NORADRENALIN; REBOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY; ARTICLE; ASTHENIA; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; FEMALE; FOLLOW UP; HAMILTON SCALE; HEART PALPITATION; HUMAN; IRRITABILITY; LIBIDO DISORDER; MALE; NERVOUSNESS; NORADRENERGIC SYSTEM; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOMETRY; SCORING SYSTEM; SPAIN; SWEATING; TACHYCARDIA; XEROSTOMIA;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIDEPRESSIVE AGENTS; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE;

EID: 20244366724     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.677     Document Type: Article

References (16)

1. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. 1999. Pharmacotherapy of attention-deficit/hyperactivity disorders reduces risk for substance abuse disorder. Pediatrics 104: e 20.
2. Buckstein OG, Brent DA, Kaminer Y 1989. Comorbidity of substance abuse and other psychiatric disorders in adolescents. Am J Psychiatry 146(9): 1131-1141.
3. De Vries TJ, Shaman Y, Homberg JR, et al. 2001. A cannabinoid mechanism in relapse to cocaine seeking. Nature Med 7(10): 1151-1154.
4. Gawin FH, Kleber HD, Byck R, et al. 1989. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46: 117.
5. Goldstein RZ, Volkow ND. 2002. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159(10): 1642-1652.
6. Jacobsen LK, Staley JK, Malinson RT, et al. 2000. Elevated central serotonin transporter. Binding availability in acutely abstinent cocaine-dependent patients. Am J Psychiatry 157: 1134-1140.
7. Kaminer Y. 1992. Clinical implications of the relationship between attention-deficit hyperactivity disorder and psychoactive substance abuse disorders. Am J Addict 1(3): 257-264.
8. Kampman KM, Volpicelli JR, Mulvaney F, et al. 2001. Effectiveness of propanolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend 63 1): 69-78.
9. Kosten TR. 1989. Pharmacotherapeutic interventions for cocaine abuse. Matching patients to treatments. J Nerv Ment Dis 177: 379-389.
10. Levin FR, Lehman AF. 1991. Meta-analysis of desipramine in the treatment of cocaine addiction. J Clin Psychopharmacol 1: 374-378.
11. Mayberg HS, Liotti M, Braman SK, et al. 1999. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156 5): 675-682.
12. Robinson TE, Berridge KC. 2001. Mechanisms of action of addictive stimuli: incentive-sensitization and addiction. Addiction 96: 103-114.
13. Weddington WW, Brown BS, Haertzen CA, et al. 1991. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 17 2): 137-152.
14. Wexler BE, Gottschalk CH, Fulleright RK, et al. 2001. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 158(1): 86-95.
15. Wilens TE, Biederman J, Price J, et al. 1996. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactive disorder. Am J Psychiatry 153(9): 1147-1153.
16. Wilens TE, Spencer TJ, Biederman J. 2000. Attention deficit/hyperactivity disorder with substance use disorders. In Attention Deficit Disorders and Comorbidities in Children, Adolescents and Adults, Brown Thomas E (ed.). American Psychiatric Press: Washington; 319-339.